Showing results (761-770 of 790) with videos related to

Sort By:
Pageof 79
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Cancers|November 11, 2022
Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer GrowthLogan Blankenship, Uday P Pratap, Xue Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 9, 2020
Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitorsBilal A Al-Jaidi, Pran Kishore Deb, Soha Taher Telfah, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone DerivativesKatharigatta N Venugopala, Nizar A Al-Shar'i, Lina A Dahabiyeh, et al.
Plos Neglected Tropical Diseases|February 12, 2014
Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha modelShantanu K Kar, Binod Sah, Bikash Patnaik, et al.
Antibiotics (Basel, Switzerland)|June 25, 2020
Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole AnaloguesKatharigatta N Venugopala, Mohammed A Khedr, Yarabahally R Girish, et al.
Antibiotics (Basel, Switzerland)|May 13, 2020
Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-<i>a</i>]quinoline Derivatives: Molecular Target Identification and Molecular Docking StudiesKatharigatta N Venugopala, Vijayakumar Uppar, Sandeep Chandrashekharappa, et al.
International Journal of Biological Macromolecules|June 26, 2024
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studiesKatharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Pageof 79